NEW YORK (GenomeWeb) – The National Cancer Institute announced that it intends to fund a series of research projects focused on merging imaging strategies and multiplexed biomarker methodologies into a single approach for cancer screening, early diagnosis, and risk assessment.

Groups participating in the initiative, the NCI said, will become part of a newly established Consortium for Imaging and Biomarkers (CIB) that will perform collaborative studies, exchange information, and leverage common resources.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.